Cargando…
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
Autores principales: | Strati, Paolo, Jallouk, Andrew, Deng, Qing, Li, Xubin, Feng, Lei, Sun, Ryan, Adkins, Sherry, Johncy, Swapna, Cain, Taylor, Steiner, Raphael E., Ahmed, Sairah, Chihara, Dai, Fayad, Luis E., Iyer, Swaminathan P., Horowitz, Sandra, Nastoupil, Loretta J., Nair, Ranjit, Hassan, Ahmed, Daoud, Taher E., Hawkins, Misha, Rodriguez, Maria A., Shpall, Elizabeth J., Ramdial, Jeremy L., Kebriaei, Partow, Hong, David S., Westin, Jason R., Neelapu, Sattva S., Green, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692290/ https://www.ncbi.nlm.nih.gov/pubmed/37389847 http://dx.doi.org/10.1182/bloodadvances.2023010653 |
Ejemplares similares
-
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma
por: Strati, Paolo, et al.
Publicado: (2020) -
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response
por: Jallouk, Andrew P., et al.
Publicado: (2022) -
ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
por: Strati, Paolo, et al.
Publicado: (2023) -
Day 30 SUV(max) predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
por: Al Zaki, Ajlan, et al.
Publicado: (2022) -
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
por: Strati, Paolo, et al.
Publicado: (2021)